%0 Journal Article %T LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia %A Ke, Shandong %A Zhou, Xiaofen %J Translational Cancer Research %D 2019 %B 2019 %9 %! LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia %K %X Background: This study aimed to investigate the regulatory role of long non-coding RNA associated with microvascular invasion in hepatocellular carcinoma ( lnc-MVIH ) in the progression of acute myeloid leukemia (AML) and the underlying mechanism. Methods: Lnc-MVIH expression was detected in AML cell lines AML-193, KG-1, HL-60, OCI-AML2 and primary normal bone marrow mononuclear cells (BMMC). The effect of lnc-MVIH knockdown on cell proliferation, apoptosis and miR-505 expression were detected by transfection of lnc-MVIH shRNA and control shRNA into KG-1 cells. And the effect of miR-505 knockdown on lnc-MVIH , cell proliferation, cell apoptosis as well as potential miR-505 target genes [ high mobility group box 1 ( HMGB1 ) and cyclin E2 ( CCNE2 )] in lnc-MVIH knockdown treated KG-1 cells was assessed by transfection of lnc-MVIH shRNA and lnc-MVIH shRNA & miR-505 shRNA into KG-1 cells. Results: Lnc-MVIH expression was elevated in AML-193, KG-1, OCI-AML2 cell lines, but similar in HL-60 cell line compared with primary normal BMMC. Lnc-MVIH knockdown inhibited cell proliferation but promoted cell apoptosis in KG-1 cells, meanwhile miR-505 expression was increased by lnc-MVIH knockdown in KG-1 cells. And in rescue experiments, miR-505 knockdown had no effect on expression of lnc-MVIH , while it increased the expressions of HMGB1 and CCNE2 , promoted cell proliferation, inhibited cell apoptosis in lnc-MVIH knockdown treated KG-1 cells. Conclusions: Lnc-MVIH knockdown inhibits cell proliferation but promotes cell apoptosis via regulating miR-505 mediated HMGB1 and CCNE2 in AML. %U https://tcr.amegroups.org/article/view/33482 %V 8 %N 7 %P 2526-2534 %@ 2219-6803